mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00073 |
1 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.00056 |
1 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.00064 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00056 |
1 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.00062 |
1 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.00055 |
1 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.00039 |
1 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.0004 |
1 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.00027 |
1 |